Zybirra 250 mg Tablet

Get a Price/Quote

Zybirra 250 mg Tablet Specification

Dosage Form
Oral Tablet

Indication
Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Salt Composition
Abiraterone Acetate 250 mg

Pacakaging (Quantity Per Box)
1 bottle of 120 Tablets

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Abiraterone Acetate

Physical Form
Tablets

Function
Anti Cancer Medication

Recommended For
Prostate Cancer Patients

Dosage
As Prescribed by Physician

Dosage Guidelines
Take on an empty stomach, one hour before or two hours after meals, or as directed by physician.

Suitable For
Adults

Quantity
120 Tablets

Storage Instructions
Store in a cool, dry place below 30°C. Protect from light and moisture.

Route of Administration
Oral

Brand Name
Zybirra

Prescription Required
Yes

Shape
Oval

Marketed By
Cadila Healthcare Ltd.

MRP (per bottle)
Information available on request

Colour
White to off-white

Shelf Life
24 Months

About Zybirra 250 mg Tablet

Featured for its formidable efficacy and pristine quality, Zybirra 250 mg Tablet is a marvelously crafted anti-cancer medication, reserved for adults battling metastatic castration-resistant prostate cancer. Oval and white to off-white in appearance, each bottle contains 120 tablets of Abiraterone Acetate. Manufactured by Cadila Healthcare Ltd., Zybirra delivers reliable, high-standard treatment with a shelf life of 24 months. Prescription is required for this last-chance therapy. Ensure optimal results by storing Zybirra in a cool, dry place below 30C, protected from light and moisture.

Application and Suitability of Zybirra 250 mg Tablet

Zybirra 250 mg Tablet is marvelously suited for adult patients diagnosed with metastatic castration-resistant prostate cancer. The tablets oral administration means its application surface is internal, acting directly within the body to inhibit cancer progression. Zybirras recommended use is strictly as prescribed by a physician, ensuring both safety and efficacy. Its pristine formulation, designed for internal medical use, positions it as a premier choice for individuals seeking advanced prostate cancer therapy.

Premium Payment Terms and Sample Policy for Zybirra

Order supply of the premium Zybirra 250 mg Tablet comes with flexible payment terms tailored to client needs. Buyers can request sample policies to assess product quality before complete order fulfillment. The main domestic market is India, with supply managed by reputable distributors and manufacturers for efficient order completion. Customers can reserve Zybirra confidently, knowing each stepfrom inquiry to final deliveryis handled with utmost care, supporting seamless acquisition of this important medication.

FAQs of Zybirra 250 mg Tablet:

Q: How should Zybirra 250 mg Tablet be stored for optimal quality?

A: Zybirra 250 mg Tablet should be stored in a cool, dry environment below 30C and protected from light and moisture to maintain its pristine quality.

Q: What is the recommended process for taking Zybirra 250 mg Tablet?

A: The tablet should be taken orally, on an empty stomach, either one hour before or two hours after meals, strictly following physician instructions.

Q: When is Zybirra 250 mg Tablet prescribed?

A: Zybirra is prescribed for adults diagnosed with metastatic castration-resistant prostate cancer (mCRPC) as part of an advanced anti-cancer treatment plan.

Q: Where can Zybirra 250 mg Tablet be purchased?

A: Zybirra 250 mg Tablet is supplied in India by Cadila Healthcare Ltd. through authorized distributors, exporters, and suppliers. Prescription is mandatory for purchase.

Q: What benefits does Zybirra 250 mg Tablet offer patients?

A: Zybirra provides formidable support in managing advanced prostate cancer, helping to slow disease progression and improve quality of life under medical supervision.